DongSheng Wen

Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial.

Li Xu, Yaojun Zhang, Wei Wei, 2022, European journal of cancer.

One day versus two days of hepatic arterial infusion with oxaliplatin and fluorouracil for patients with unresectable hepatocellular carcinoma

Li Xu, Wei Wei, Xuan Lin, 2022, BMC Medicine.

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective Trials

Zhongguo Zhou, Li Xu, Yaojun Zhang, 2022, Technology in cancer research & treatment.

A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma

Xuan Lin, Luyao Ma, Anna Kan, 2022, Cancer Cell International.

Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular Carcinoma

Minshan Chen, Yaojun Zhang, Wei Wei, 2021, Frontiers in Oncology.

MZF1 promotes tumour progression and resistance to anti-PD-L1 antibody treatment in hepatocellular carcinoma

Anna Kan, Haijing Deng, YeXing Huang, 2023, JHEP reports : innovation in hepatology.

Comprehensive characterization of enhancer RNA in hepatocellular carcinoma reveals three immune subtypes with implications for immunotherapy

Xuan Lin, M. Shi, Anna Kan, 2022, Molecular therapy oncolytics.